HOYA Corporation
7741
Κατάταξη σε μετοχές
#417
Globally recognized as a med-tech innovator, HOYA Corporation is a prominent... Globally recognized as a med-tech innovator, HOYA Corporation is a prominent provider of advanced technology and healthcare solutions worldwide. Its comprehensive portfolio of life care products encompasses vision correction items such as eyeglasses and contact lenses, alongside sophisticated medical devices including endoscopes, intraocular lenses, and surgical instruments for laparoscopic procedures. HOYA also supplies automated endoscope cleaning systems and various medical essentials like prosthetic ceramic fillers and metallic implants. Complementing its medical offerings, the company operates Eyecity, a specialized retail chain for contact lenses. In the realm of information technology, HOYA manufactures crucial components such as mask blanks and photomasks for semiconductor and liquid crystal display fabrication, as well as glass disks for hard disk drives. Its imaging products segment includes optical glasses, specialized lenses, colored glass filters, and laser/UV light source equipment. Furthermore, the company extends its expertise into software and cloud services, offering ReadSpeaker, a speech synthesis application, and cloud platforms like Kinnosuke for time and attendance management, and Yonosuke for electronic payslip distribution. HOYA Corporation, established in 1941, is headquartered in Tokyo, Japan.
Τιμή μετοχής
$170.48
Κεφαλαιοποίηση
$57.03B
Αλλαγή (1 ημέρα)
1.60%
Αλλαγή (1 έτος)
12.48%
Χώρα
JP
Εμπόριο HOYA Corporation (7741)
Κατηγορία
Healthcare
Κέρδη για την HOYA Corporation (7741)
Κέρδη τον 2026 TTM: 0
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της HOYA Corporation, τα τρέχοντα κέρδη της εταιρείας είναι 0. Το 2026, η εταιρεία παρουσίασε κέρδη 0, ίσο με των κερδών του 2026 που ήταν 0. Τα κέρδη που εμφανίζονται σε αυτή τη σελίδα είναι πριν από τόκους και φόρους, γνωστά και ως EBIT.
Ιστορικό κερδών για την HOYA Corporation από 2001 έως 2026
Κέρδη στο τέλος κάθε έτους
| Έτος | Κέρδη | Αλλαγή |
|---|---|---|
| 2025 | $1.73B | 10.96% |
| 2024 | $1.56B | -3.85% |
| 2023 | $1.63B | -6.07% |
| 2022 | $1.73B | 20.38% |
| 2021 | $1.44B | 4.95% |
| 2020 | $1.37B | 5.11% |
| 2019 | $1.30B | 11.44% |
| 2018 | $1.17B | 17.56% |
| 2017 | $994.72M | -6.03% |
| 2016 | $1.06B | 7.37% |
| 2015 | $985.90M | 18.95% |
| 2014 | $828.82M | -12.61% |
| 2013 | $948.37M | 45.65% |
| 2012 | $651.14M | -14.66% |
| 2011 | $763.00M | 41.14% |
| 2010 | $540.59M | 20.74% |
| 2009 | $447.73M | -52.78% |
| 2008 | $948.20M | 4.41% |
| 2007 | $908.13M | 9.72% |
| 2006 | $827.68M | -9.00% |
| 2005 | $909.58M | 13.48% |
| 2004 | $801.51M | 229.71% |
| 2003 | $243.09M | -14.30% |
| 2002 | $283.65M | 12.92% |
| 2001 | $251.20M | 0.00% |
Κέρδη παρόμοιων εταιρειών ή ανταγωνιστών
| Εταιρεία | Κέρδη | Διαφορά Κερδών | Χώρα |
|---|---|---|---|
| $3.62B | - |
US
|
|
| $4.11B | - |
FR
|
|
| $1.59B | - |
US
|
|
| - | - |
CH
|
|
| - | - |
US
|
